Sitemap
August 25, 2023 Articles
Filter by Available Specialty
- ARCHER trial highlights protective effects of ANX007 on visual function
- Asian patients may experience earlier mycosis fungoides diagnosis, better outcomes
- Biomarkers may predict risk for advanced prostate cancer among Black men
- BLOG: What does ‘rare’ actually mean when communicating with patients?
- Blood test helps predict risk for lung cancer mortality
- CDC launches anti-sepsis program for US hospitals
- Colchicine not protective against AF, myocardial injury after noncardiac chest surgery
- COVID-19 pandemic led to delayed melanoma diagnoses, more advanced tumors
- Date set for CDC advisors to vote on new COVID-19 boosters
- Disentangling long COVID from fibromyalgia: Patients often feel ‘disrespected, ignored’
- Dupilumab use correlates with S. aureus reductions, atopic dermatitis improvements
- Embracing change: ‘Move health care forward’ with virtual care partnerships
- Examining the blood collection experience
- FDA approves Tysabri biosimilar Tyruko for relapsing forms of multiple sclerosis
- FDA designates Draeger Medical Carina Sub-Acute Care Ventilator recall as class I
- From AI screening to invisible hearing aids: A recap of top news in eye care technology
- Large cementless stems may increase risk of THA revision for periprosthetic fracture
- Nasal IL-13 production indicates patients with late allergic responses to birch
- Obesity and cancer: Shedding light on a growing health concern
- Older female colorectal cancer survivors often experience persistent GI symptoms
- Patients with patella alta may experience less severe cartilage damage after instability
- Psychological distress may be linked to poor self-management of chronic kidney disease
- Q&A: Early diagnosis key in successful uterine fibroid prevention, treatment
- Rapport Therapeutics raises $150M in funding to advance neuromedicine platform
- Semaglutide drives ‘substantial’ improvements in heart failure symptoms: STEP-HFpEF
- Study highlights sex disparities in participation during virtual academic meetings
- Teprotumumab, tocilizumab improve thyroid eye disease symptoms within 24 weeks
- Top in allergy/asthma: Inhaler technique retraining; mobile app for asthma control
- Treating atrial high-rate episodes with edoxaban not effective, may be harmful
- VIDEO: Quick results, safety, reversibility benefits of phakic IOL implantation